Servier Loses Bid To Enforce EU Pay-For-Delay Ruling In UK

Law360, London (November 6, 2020, 3:21 PM GMT) -- Britain's highest court ruled on Friday that Servier Laboratories cannot rely on an EU court ruling to fight allegations in England that it blocked generic competition to its blood pressure medication because it could be overturned.

The Supreme Court unanimously dismissed the appeal brought by the international pharmaceutical company, which had sought to hold the English courts to a European Union General Court ruling that it did not hold potentially anti-competitive dominance over the market.

Justice David Lloyd-Jones said the findings are not binding and that Servier's attempts are "premature" because they could be "reversed or rendered redundant" by the European Court of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!